Century Therapeutics SVP Douglas Carr sells $3,199 in shares
At a glance
- $IPSC today−17.1%last $1.36
- Vs industry peers−16.19 pts6-peer median −0.88% · far behind
- Since Sep 15−26.9%from the first trade after the story
- 52-week range199.6% above low$0.45 – $3.04
- In the headline$3,199Amount
- Coverage1 this week1 in 30 days · too few stories to call a pace
Nothing reported about century therapeutics across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: This one turns on a concrete figure ($3,199); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $IPSC -17.07% in the latest session.
- Timing: It was published after the close, so the day's move was settled before the story existed. The next session is the first that could react.
Where the stock stands
Century Therapeutics ($IPSC) tumbled 17.07% to $1.36 in the latest session. Over the past month it is down 6.8%. That leaves it 55% below its 52-week high of $3.04 and 200% above its low of $0.45. It has been a volatile year: the high was 6.7 times the low, so moves this size are not unusual for it.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed one newer story on Century Therapeutics, published this week. It reads bullish.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $IPSC page, and they say what management has disclosed without a reporter in between. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. To run the numbers yourself, ask Wook AI above about $IPSC: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 15, 2026. $IPSC has moved -26.88% ($1.86 to $1.36). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
